Li Du Plastic
Li Du Plastic is a NEEQ-listed medical aesthetics hospital in Wuxi, China, founded in 2009, offering plastic surgery, dermatology, and minimally invasive cosmetic procedures to individual consumers through a single flagship location with five director-level physicians.
- Company typePrivate
- Founded2009
- HeadquartersWuxi Shi, China
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Li Du Plastic does
Li Du Plastic Surgery Hospital (丽都整形美容医院) is a privately-held, NEEQ-listed (ticker 834480) medical aesthetics institution headquartered at 819-821 Zhongshan Road, Liangxi District, Wuxi, Jiangsu Province, China. Founded in 2009 and operating for over 15 years, the hospital delivers a full-spectrum portfolio of cosmetic surgical and non-surgical procedures organized into three service lines: plastic surgery (eye, nose, facial contouring, liposuction), skin care (whitening, hair removal, pigmentation/acne treatment, RF skin tightening, chemical peel), and minimally invasive aesthetics (dermal fillers, botulinum, thread lifts). The clinical team is anchored by five named directors with formal credentials, manufacturer certifications (Allergan, Lumenis, Thermage, FOTONA4D), and individually attributed proprietary techniques such as the Three-Dimensional Layered Injection and Dynamic Meimo 3.0.
The hospital operates on a direct-to-consumer, single-location model. Patients are acquired through a professional website with embedded real-time online consultation (Kuaishang), a beauty hotline (0510-66686666), and WeChat-driven promotional pricing (e.g., double eyelid surgery at ¥980, rhinoplasty at ¥1,680, skin booster at ¥280). Revenue is generated entirely from individual one-time procedures and follow-up treatment packages — no subscription or membership pricing is offered. The facility runs 08:30–19:30 daily without holidays and reports 21+ successful daily bookings plus an active consultation pipeline (10 busy experts / 2 idle at snapshot). Distribution is direct only, with no third-party reseller, franchise, or channel-partner model disclosed.
Commercially, the company has scaled its top line at a ~37% CAGR between 2014 and 2017 (¥28.0M → ¥72.6M), funded in part by a ¥80M investment from Fosun Capital in January 2017 and supported by a NEEQ listing. The hospital has held industry-leadership positions (Vice-President Unit of the Jiangsu Province Plastic Surgery Association, host of the Jiangsu Plastic Surgery Annual Summit) and a stable regional brand identity. However, 2017 EBITDA turned negative, signaling margin pressure, and growth beyond a single Wuxi site remains unconfirmed in available data, leaving the post-2017 trajectory materially uncertain.
Li Du Plastic firmographics
Firmographics- Name
- Li Du Plastic
- Legal name
- 丽都整形美容医院股份有限公司
- Website
- https://ruilimr.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Li Du Plastic is a NEEQ-listed medical aesthetics hospital in Wuxi, China, founded in 2009, offering plastic surgery, dermatology, and minimally invasive cosmetic procedures to individual consumers through a single flagship location with five director-level physicians.
- Ownership category
- akta.pro rank
Li Du Plastic industry classification
Industry- Product category
- Medical Aesthetics / Cosmetic Surgery Services
- NAICS
- Other Personal Care Services (81219)
- akta.pro primary industry
- Plastics / Cosmetic & Dermatologic Surgery Centers (HLAFAIAK)
- akta.pro secondary industry
- Medical-Grade / Clinical Facials (Dermatology & Med Spa) (HSALADAN)
Keywords
Where Li Du Plastic is headquartered
LocationHeadquarters
- HQ city
- Wuxi Shi
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Li Du Plastic business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Aesthetic Procedures: The hospital generates revenue from a broad portfolio of surgical and non-surgical aesthetic procedures, including plastic surgery (eye, nose, face, liposuction), skin rejuvenation (laser, chemical peel, RF skin tightening), and minimally invasive injectables (Botox, fillers, skin boosters). Procedures are priced individually with promotional/single-session pricing visible on the website.
- Consultation and Follow-up Services: Revenue is also generated through consultation fees, follow-up treatments, and bundled procedure packages. The hospital operates an online consultation platform with real-time customer service tracking daily bookings and ongoing consultations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual procedure promotional pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Li Du Plastic product offering
Product offeringCore offering
Li Du Plastic operates a comprehensive medical aesthetics hospital in Wuxi offering three core service categories: Plastic Surgery (eye, nose, facial contouring, and liposuction procedures), Skin Care (whitening/brightening, hair removal, pigmentation/acne removal, RF skin tightening, and chemical peels), and Minimally Invasive Procedures (dermal fillers, anti-wrinkle injectables, and thread lifts). The hospital provides personalized "private custom" treatment plans combining Eastern aesthetics with modern techniques and serves individual consumers seeking cosmetic enhancement.
Product overview
Li Du Plastic Surgery Hospital (丽都整形美容医院) is a comprehensive medical aesthetics institution offering surgical and non-surgical cosmetic procedures. The hospital provides a portfolio of services organized into three main categories: Plastic Surgery (眼部整形, 鼻部整形, 面部整形, 溶脂抽脂), Skin Care (美白嫩肤, 多维脱毛, 祛斑祛痘, 电波拉皮, 果酸换肤), and Minimally Invasive Procedures (填充塑形, 除皱抗衰, 微创提拉). The hospital also features signature techniques developed by its specialist doctors, including Q弹蜜桃胸 breast augmentation, 双C骨相美鼻 rhinoplasty, MD-Codes injection techniques, and 3D thread lift procedures. Additional specialized services include laser treatments (调Q激光, 皮秒激光, FOTONA4D, 热玛吉, 热拉提, 超声刀), injectable treatments (玻尿酸, 埋线提升), and comprehensive facial rejuvenation protocols combining multiple modalities.
Differentiator
Problem solved
Functional benefit
Products and services
- Eye Plastic Surgery (眼部整形) Surgical procedures for eyelid enhancement and eye-area aesthetics, including double eyelid surgery (promotional price ¥980) and proprietary Dynamic Meimo 3.0 technique. Targeted at consumers seeking natural-looking eye-area rejuvenation.
- Nose Plastic Surgery (鼻部整形) Nose reshaping and reconstruction procedures including nasal augmentation and the proprietary Dual-C Bone Structure Nose technique for harmonious facial proportions. Promotional price: ¥1,680 per procedure.
- Facial Surgery (面部整形) Comprehensive facial contouring and reshaping surgical procedures, including the proprietary Contour Fixation and Lifting technique for structural support and rejuvenation.
- Liposuction (溶脂抽脂) Multi-dimensional layered liposuction for body contouring and fat removal, using both surgical and laser-assisted lipolysis approaches.
- Skin Whitening / Brightening (美白嫩肤) Skin whitening and brightening treatments for improved complexion using laser and intense pulsed light technologies.
- Multi-dimensional Hair Removal (多维脱毛) Comprehensive hair removal treatments using laser and light-based technologies for long-term hair reduction.
- Freckle / Acne Removal (祛斑祛痘) Laser-based treatment for spots, freckles, pigmentation, and acne using Q-switched laser and other light-based technologies. Promotional price for spot/pigmentation removal: ¥880.
- Radiofrequency Skin Tightening (电波拉皮) Radiofrequency-based non-surgical skin lifting and tightening procedure (Thermolift / RF skin tightening) for facial rejuvenation.
- Chemical Peel (果酸换肤) Alpha-hydroxy acid chemical peel exfoliation treatment for skin rejuvenation and improved skin texture.
- Dermal Filler / Contouring (填充塑形) Dermal filler injections (hyaluronic acid) for facial contouring and volume restoration, using proprietary Three-dimensional Layered Injection Technique and Multi-Point Multi-Level Linkage Injection Method. Promotional price: ¥680.
- Anti-wrinkle / Aging Treatment (除皱抗衰) Treatments targeting wrinkles and signs of aging, including botulinum toxin (Botox) injections, hyaluronic acid fillers, and energy-based devices (Ultherapy, Thermage). Promotional wrinkle injection: ¥380.
- Minimally Invasive Lifting (微创提拉) Minimally invasive face lifting procedures including thread lifts (埋线提升), with proprietary techniques such as 3D Comprehensive Thread Lift Rejuvenation.
- Comprehensive Facial Rejuvenation Management (面部年轻化综合管理) Comprehensive treatment protocol combining multiple technologies (Botox, fillers, thread lifts, RF, ultrasound, laser) for complete facial anti-aging and rejuvenation results.
- Bouncy Peach Breast Surgery (Q弹蜜桃胸) Proprietary breast augmentation technique for natural, perky results, performed under Director Chen Guangping.
- MD-Codes Aesthetic Refinement (MD-Codes美学精修) Dr. Chen Guangping's specialized injection technique based on MD Codes facial aesthetics principles for precise facial sculpting with fillers.
- Dynamic Beautiful Eyes 3.0 (灵动媚眼3.0) Proprietary eyelid surgery technique for natural-looking eye enhancement, combining multiple surgical approaches.
- Non-scarring Eye Bag Removal (无痕祛眼袋) Scarless surgical removal of under-eye bags using advanced surgical techniques for natural eye-area rejuvenation.
- Minimally Invasive Brow Lift (微创提眉术) Minimal incision brow lifting procedure performed for upper-face rejuvenation and brow positioning.
- Intimate Health Management (私密健康管理) Specialized laser-based treatments for female intimate area rejuvenation and health management.
- 3D Comprehensive Thread Lift Rejuvenation (3D综合线雕逆龄术) Three-dimensional thread lifting technique for comprehensive facial rejuvenation and contour lifting using absorbable threads.
- Multi-point Multi-layer Linkage Injection (多点多层面联动注射法) Dr. Yu Zhenhua's proprietary injection technique for precise filler placement, enabling refined facial contouring through coordinated multi-layer injection at multiple points.
- Dual-C Bone Structure Nose (双C骨相美鼻) Facial bone structure-based rhinoplasty technique designed to create harmonious facial proportions through anatomical structural analysis.
- Contour Fixation and Lifting (轮廓固定提升) Facial contouring technique combining structural support and lifting to address facial aging and reshaping needs.
- Jaw Slimming Injection (瘦脸针) Botulinum toxin injection targeting the masseter muscle to reduce jaw width and create a slimmer facial contour. Promotional price: ¥580 per session.
- Skin Booster / 水光针 (Mesotherapy) Mesotherapy / skin booster injection using hyaluronic acid for skin hydration, radiance, and rejuvenation. Promotional price: ¥280 per session.
Quantifiable outcome
- Daily appointment capacity: 21+ successful bookings per day as tracked on the online platform
Companies that use Li Du Plastic
Customer profileSegments1 record
Ideal customer profiles1 record
Li Du Plastic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Li Du Plastic partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 江苏整形医学美容年度峰会 (Jiangsu Plastic Surgery Medical Aesthetics Annual Summit)minorLidu Plastic Surgery Hospital served as the host/co-organizer (丽都承办) of the Jiangsu Province Plastic Surgery Medical Aesthetics Annual Summit and the China-US-Japan-Korea Global High-Level Forum. This is a co-branded industry event that positions Lidu as a thought leader and regional host.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Li Du Plastic competitors and assessment
Company assessmentDirect peers
- Pengai Medical Group (医美国际): NASDAQ-listed (AIH) Chinese medical aesthetics hospital chain offering surgical and non-surgical cosmetic procedures across multiple cities. Directly comparable as a hospital-based aesthetic medicine provider serving Chinese consumers, though Pengai is significantly larger and multi-site.
- Raily Aesthetic Medicine (瑞丽医美): Hong Kong-listed (HKEX: 2135) Chinese medical aesthetics provider with multiple clinic locations offering plastic surgery, dermatology, and minimally invasive procedures. Most directly comparable public peer in scope of services, customer type (Chinese aesthetic consumers), and use of named physician technique branding.
- Yestar Aesthetic Medicine (艺星医疗): Major Chinese aesthetic medicine hospital chain offering plastic surgery and skin aesthetic services across multiple provinces. Comparable as a chain-based medical aesthetics brand targeting Chinese consumers, though Yestar operates at significantly larger scale.
- Huahan Medical Group (华韩医疗): NEEQ-listed (formerly) Chinese medical aesthetics hospital group. Comparable as a publicly listed aesthetic hospital business in China with overlapping service mix of surgical and non-surgical cosmetic procedures.
- Meilai Aesthetic Hospital (美莱医疗美容): One of the largest Chinese aesthetic medicine chains with 30+ cities. Comparable as a multi-tier Chinese aesthetic hospital brand, but materially larger and more geographically diversified than Li Du's single Wuxi location.
Broad incumbents
- Fosun Pharma (复星医药): Major Chinese pharmaceutical and healthcare conglomerate and Li Du's institutional investor (via Fosun Capital). Comparable as the parent strategic ecosystem that could enable Li Du's expansion, and as a broader incumbent in Chinese healthcare with adjacency to aesthetic medicine.
- Sisram Medical (复锐医疗科技): Hong Kong-listed (HKEX: 1696) energy-based aesthetic device maker with Chinese parentage (Fosun). Comparable as a supplier-side participant in the same Chinese aesthetic medicine ecosystem; also represents the upstream device technology Li Du deploys in laser/RF treatments.
- Lanz Group (朗姿股份): Shenzhen-listed Chinese apparel conglomerate that has expanded into medical aesthetics via subsidiaries. Comparable as a Chinese public company with an aesthetic medicine business segment, though Lanz's primary identity remains apparel.
Regional players
- EC Healthcare (医思健康): Hong Kong-listed (HKEX: 2138) provider of medical, dental, and aesthetic services primarily in Hong Kong and Greater Bay Area. Comparable as a multi-modality medical aesthetics services group in the Chinese-language market, but geographically distinct from Li Du's Jiangsu focus.
- ID Hospital (韩国ID医院): Major Korean plastic surgery hospital chain serving both domestic Korean patients and large flows of Chinese medical tourists. Comparable as a hospital-based aesthetic surgery provider whose techniques and physician training are widely emulated in the Chinese market that Li Du serves.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Li Du Plastic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Li Du Plastic leadership team
Management profileNumber of profiles
Profiles5 records
Li Du Plastic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Li Du Plastic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Li Du Plastic
What does Li Du Plastic do?
Li Du Plastic operates a comprehensive medical aesthetics hospital in Wuxi offering three core service categories: Plastic Surgery (eye, nose, facial contouring, and liposuction procedures), Skin Care (whitening/brightening, hair removal, pigmentation/acne removal, RF skin tightening, and chemical peels), and Minimally Invasive Procedures (dermal fillers, anti-wrinkle injectables, and thread lifts). The hospital provides personalized "private custom" treatment plans combining Eastern aesthetics with modern techniques and serves individual consumers seeking cosmetic enhancement.
Is Li Du Plastic a public or private company?
Li Du Plastic is a private company. It is classified as public and is currently operating.
When was Li Du Plastic founded?
Li Du Plastic was founded in 2009. It employs 251 to 500 people.
Where is Li Du Plastic based?
Li Du Plastic is headquartered in Wuxi Shi, China, in the Asia region.
How does Li Du Plastic make money?
Two revenue lines are on record. Medical Aesthetic Procedures are the primary driver. The others are consultation and Follow-up Services.
Who are Li Du Plastic's main competitors?
Direct peers on record are Pengai Medical Group (医美国际), Raily Aesthetic Medicine (瑞丽医美), Yestar Aesthetic Medicine (艺星医疗), Huahan Medical Group (华韩医疗) and Meilai Aesthetic Hospital (美莱医疗美容). Broad incumbents are Fosun Pharma (复星医药), Sisram Medical (复锐医疗科技) and Lanz Group (朗姿股份). Regional players are EC Healthcare (医思健康) and ID Hospital (韩国ID医院).
Does Li Du Plastic have an API?
No public API is recorded for Li Du Plastic.
What industry is Li Du Plastic in?
Li Du Plastic's product category is Medical Aesthetics / Cosmetic Surgery Services. Its primary akta.pro industry code is HLAFAIAK, Plastics / Cosmetic & Dermatologic Surgery Centers, with a secondary code of HSALADAN, Medical-Grade / Clinical Facials (Dermatology & Med Spa). Its NAICS code is 81219.